KAZIA LAUNCHES PRECLINICAL COLLABORATION WITH QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE AND ANNOUNCES PATENT FILING
SYDNEY, Dec. 15, 2022 /PRNewswire/ -- Kazia Therapeutics Minimal (NASDAQ: KZIA ASX: KZA), an oncology-targeted drug growth business, is pleased to...